Detalhe da pesquisa
1.
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10).
BMC Cancer
; 17(1): 265, 2017 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28407750
2.
Pertuzumab as second or laterline therapy for human epidermal growth factor receptor 2positive metastatic breast cancer: A clinical experience.
Mol Clin Oncol
; 19(1): 52, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37303973
3.
Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program.
Clin Genitourin Cancer
; 15(3): e315-e323, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27450512